1 Chang ML, Liaw YF. Hepatitis b flares in chronic hepatitis b: Pathogenesis, natural course, and management. J Hepatol 2014, 61: 1407-1417.
2 Knolle PA, Thimme R. Hepatic immune regulation and its involvement in viral hepatitis infection. Gastroenterology 2014, 146: 1193-1207.
3 Thursz M, Yee L, Khakoo S. Understanding the host genetics of chronic hepatitis b and c. Semin Liver Dis 2011, 31: 115-127.
4 Zeng Z. Human genes involved in hepatitis b virus infection. World J Gastroenterol 2014, 20: 7696-7706.
5 Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, et al. The global burden of viral hepatitis from 1990 to 2013: Findings from the global burden of disease study 2013. Lancet 2016, 388: 1081-1088.
6 Tuncbilek S. Relationship between cytokine gene polymorphisms and chronic hepatitis b virus infection. World J Gastroenterol 2014, 20: 6226-6235.
7 Pan CJ, Wu HL, Kuo SF, Kao JH, Tseng TC, Liu CH, Chen PJ, et al. Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis b. Hepatol Int 2012, 6: 591-597.
8 Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, May LT, Ray A, Sehgal PB, et al. The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988, 3: 8-16.
9 Rincon M, Irvin CG. Role of il-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 2012, 8: 1281-1290.
10 Tang S, Yuan Y, He Y, Pan D, Zhang Y, Liu Y, Liu Q, et al. Genetic polymorphism of interleukin-6 influences susceptibility to hbv-related hepatocellular carcinoma in a male chinese han population. Hum Immunol 2014, 75: 297-301.
11 Xia C, Liu Y, Chen Z, Zheng M. Involvement of interleukin 6 in hepatitis b viral infection. Cell Physiol Biochem 2015, 37: 677-686.
12 Wang L, Zou ZQ, Wang K. Clinical relevance of hla gene variants in hbv infection. J Immunol Res 2016, 2016: 9069375.
13 Zhou C, Jin X, Tang J, Fei J, Gu C, Chen X. Association of cd40 -1c/t polymorphism in the 5'-untranslated region with chronic hbv infection. Cell Physiol Biochem 2015, 35: 83-91.
14 Matsuura K, Isogawa M, Tanaka Y. Host genetic variants influencing the clinical course of hepatitis b virus infection. J Med Virol 2016, 88: 371-379.
15 Smith AJ, D'Aiuto F, Palmen J, Cooper JA, Samuel J, Thompson S, Sanders J, et al. Association of serum interleukin-6 concentration with a functional il6 -6331t>c polymorphism. Clin Chem 2008, 54: 841-850.
16 Yang L, Sun MJ, Liu JW, Xu Q, Yuan Y. Il-6-6331 (t/c, rs10499563) is associated with decreased risk of gastric cancer in northern chinese. Asian Pac J Cancer Prev 2013, 14: 7467-7472.
17 Zhang JZ, Liu CM, Peng HP, Zhang Y. Association of genetic variations in il-6/il-6r pathway genes with gastric cancer risk in a chinese population. Gene 2017, 623: 1-4.
18 Chang WT, Huang MC, Chung HF, Chiu YF, Chen PS, Chen FP, Lee CY, et al. Interleukin-6 gene polymorphisms correlate with the progression of nephropathy in chinese patients with type 2 diabetes: A prospective cohort study. Diabetes Res Clin Pract 2016, 120: 15-23.
19 Farhat SB, de Souza CM, Braosi AP, Kim SH, Tramontina VA, Papalexiou V, Olandoski M, et al. Complete physical mapping of il6 reveals a new marker associated with chronic periodontitis. J Periodontal Res 2017, 52: 255-261.
20 Shi TY, Zhu ML, He J, Wang MY, Li QX, Zhou XY, Sun MH, et al. Polymorphisms of the interleukin 6 gene contribute to cervical cancer susceptibility in eastern chinese women. Hum Genet 2013, 132: 301-312.
21 Zhao XM, Gao YF, Zhou Q, Pan FM, Li X. Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis b virus infection. World J Gastroenterol 2013, 19: 6888-6893.
22 MacQuarrie KL, Fong AP, Morse RH, Tapscott SJ. Genome-wide transcription factor binding: Beyond direct target regulation. Trends Genet 2011, 27: 141-148.
23 Chen M, Li T, Lin S, Bi D, Zhu D, Shang Q, Ma C, et al. Association of interleukin 6 gene polymorphisms with genetic susceptibilities to spastic tetraplegia in males: A case-control study. Cytokine 2013, 61: 826-830.
24 Motawi T, Shaker OG, Hussein RM, Houssen M. Polymorphisms of alpha1-antitrypsin and interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis c virus infection. Balkan J Med Genet 2016, 19: 35-44.
25 Wang J, Chen R, Tang S, Lv X, Wu S, Zhang Y, Xia Y, et al. Analysis of il-6, stat3 and hspa1l gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study. PLoS One 2015, 10: e0118862.
26 Park BL, Lee HS, Kim YJ, Kim JY, Jung JH, Kim LH, Shin HD. Association between interleukin 6 promoter variants and chronic hepatitis b progression. Exp Mol Med 2003, 35: 76-82.
27 Lu Y, Peng J, Wang C, Zhu Y, Wang F, Sun Z. Il-6 promoter functional polymorphism -572c/g affects spontaneous clearance of hepatitis b virus infection. Clin Lab 2014, 60: 1903-1907.
28 Chen J, Liu RY, Yang L, Zhao J, Zhao X, Lu D, Yi N, et al. A two-snp il-6 promoter haplotype is associated with increased lung cancer risk. J Cancer Res Clin Oncol 2013, 139: 231-242.